BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2001
View Archived Issues
New therapeutic areas unfold for galantamine
Read More
NeoPharm seeks orphan drug status for IL-13-PE38
Read More
Atrix licenses novel growth-promoting peptide from Tulane
Read More
Pump therapy with insulin aspart approved by EMEA
Read More
Antifibrotic compounds the focus of a FibroGen/Sankyo collaboration
Read More
Nonfeminizing estrogen targeting neurodegenerative diseases completes phase I
Read More
Novel chelator designed by D-Pharm commences phase II clinical development for stroke
Read More
DB-289 enters phase II trials in Africa for trypanosomiasis
Read More
Oralin is a suitable substitute for injected insulin according to EASD presentations
Read More
Intercalating agent may be useful in MS; preclinical data presented at ECTRIMS 2001
Read More
Increase in ACh efflux may underlie cognition-improving effects of atypical antipsychotics
Read More
FDA requires further information for approval of Plenaxis
Read More
Evidence presented in Nice supports lavender aromatherapy in dementia-associated agitation
Read More
Novartis launches NAVIGATOR trial for diabetes and cardiovascular disease prevention
Read More
Stimulation of exocytosis from pancreatic beta-cells by imidazolines is PLA2-dependent
Read More
Cell Pathways completes phase I study of Aptosyn/Taxotere combination regimen, phase II begins
Read More
New glucose transport stimulator under study at Korean centers
Read More
Epimmune updates HIV vaccine program
Read More
First clinical data on peptide for autoimmune diabetes presented during EASD meeting
Read More
Promising preclinical results reported for Cel-Sci's HIV immunotherapeutic
Read More
Phase I rhASB trial successfully meets its primary objective
Read More
Rituximab now available in Japan
Read More
Urotensin-II receptor antagonists discovered by GSK team
Read More
Boehringer Ingelheim reports new piperazine MTP inhibitors
Read More
Antithrombotic benzimidazoles in early research at Boehringer Ingelheim
Read More
Joint research at Karo Bio and Abbott leads to liver-selective GR antagonists
Read More
Subtype-selective nAChR ligands designed at British university
Read More